Trial · NCT00550862
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind Phase (Day 1 to Day 85) | STARTED | Obeticholic Acid (OCA) 10 Milligrams (mg) | 38 | |
| Double-Blind Phase (Day 1 to Day 85) | STARTED | OCA 25 mg | 48 | |
| Double-Blind Phase (Day 1 to Day 85) | STARTED | OCA 50 mg | 41 | |
| Double-Blind Phase (Day 1 to Day 85) | STARTED | Placebo | 38 | |
| Double-Blind Phase (Day 1 to Day 85) | STARTED | LTSE OCA Total | 0 | |
| Double-Blind Phase (Day 1 to Day 85) | COMPLETED | Obeticholic Acid (OCA) 10 Milligrams (mg) | 32 | |
| Double-Blind Phase (Day 1 to Day 85) | COMPLETED | OCA 25 mg | 42 | |
| Double-Blind Phase (Day 1 to Day 85) | COMPLETED | OCA 50 mg | 25 | |
| Double-Blind Phase (Day 1 to Day 85) | COMPLETED | Placebo | 37 | |
| Double-Blind Phase (Day 1 to Day 85) | COMPLETED | LTSE OCA Total | 0 | |
| Double-Blind Phase (Day 1 to Day 85) | NOT COMPLETED | Obeticholic Acid (OCA) 10 Milligrams (mg) | 6 | |
| Double-Blind Phase (Day 1 to Day 85) | NOT COMPLETED | OCA 25 mg | 6 | |
| Double-Blind Phase (Day 1 to Day 85) | NOT COMPLETED | OCA 50 mg | 16 | |
| Double-Blind Phase (Day 1 to Day 85) | NOT COMPLETED | Placebo | 1 | |
| Double-Blind Phase (Day 1 to Day 85) | NOT COMPLETED | LTSE OCA Total | 0 | |
| LTSE Phase (Up to 12 Months) | STARTED | Obeticholic Acid (OCA) 10 Milligrams (mg) | 0 | |
| LTSE Phase (Up to 12 Months) | STARTED | OCA 25 mg | 0 | |
| LTSE Phase (Up to 12 Months) | STARTED | OCA 50 mg | 0 | |
| LTSE Phase (Up to 12 Months) | STARTED | Placebo | 0 | |
| LTSE Phase (Up to 12 Months) | STARTED | LTSE OCA Total | 78 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00550862/flow